** Shares of New Zealand's Heartland Group HGH.NZ fall
1.9% to NZ$1.52 as of 0308 GMT
** Analysts at Macquarie lower price target on the financial
conglomerate to NZ$1.53 from NZ$1.68, maintain "neutral" rating
** Macquarie cuts FY24 net profit after tax (NPAT) forecast
to 14% below brokerage's prior estimate, citing cost incurred in
Challenger Bank acquisition
** Two of four analysts rate the stock "buy" and two "hold;"
their median PT is NZ$1.82 – LSEG data
** Stock down ~14% this year, as of last close
(Reporting by Megha Rani)
((Megha.Rani2@thomsonreuters.com;))